Le Lézard
Classified in: Health
Subjects: HSP, AVO

March of Dimes Statement on Marijuana Use in Pregnancy


ARLINGTON, Va., Aug. 29, 2019 /PRNewswire/ -- March of Dimes today released the following statement from Rahul Gupta, MD, MPH, MBA, FACP, Chief Medical & Health Officer, Senior Vice President, in response to the release of the U.S. Surgeon General's Advisory: Marijuana Use and the Developing Brain

March of Dimes Foundation Logo (PRNewsfoto/March of Dimes Foundation)

"March of Dimes applauds today's release of the US Surgeon General's Advisory on the dangers of marijuana use during pregnancy for both mom and baby. The evidence clearly shows that no amount of marijuana has been proven safe to use during pregnancy or while breastfeeding. Unfortunately, this message is not resonating with all expecting women and maternity care providers, and marijuana use among pregnant women has doubled between 2002 and 2017.

"According to data from the National Survey on Drug Use and Health, cannabis use in pregnant women has more than doubled over the past 15 years, from 3.4 percent to 7 percent, and use is more common during the first trimester of pregnancy. A National Institute on Drug Abuse study found cannabis use during pregnancy has been associated with effects on fetal growth, including low birth weight and length, and these outcomes may be more likely among women who consume marijuana frequently during pregnancy, especially in the first and second trimesters.

"Today's advisory and its associated digital campaign are critical to raising awareness among the public about the detrimental impact exposure to elta-9-tetrahydrocannabinol (THC) has on an infant's developing brain in utero. March of Dimes also applauds the Department of Health and Human Services' commitment to accelerating research on the health effects of marijuana, and encourages the Department to prioritize pregnant women and their infants in that research.

"March of Dimes encourages women who are pregnant and considering using marijuana to treat the side effects of pregnancy to consult with their health care provider to identify treatments that are safer for both mom and baby. Further, pregnant women struggling with substance use disorders should seek assistance from their health care provider to begin appropriate treatment."

March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family. Visit marchofdimes.org or nacersano.org for more information. Visit shareyourstory.org for comfort and support. Find us on Facebook and follow us on Instagram and Twitter.

 

SOURCE March of Dimes


These press releases may also interest you

at 11:35
SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac...

at 11:30
SkyQuest projects that the nanotechnology market will attain a value of USD 53.51 billion by 2031, with a CAGR of 36.4% over the forecast period (2024-2031). The increasing demand for nanotechnology in medical research fuels the demand. During...

at 11:30
The Arnold and Mabel Beckman Foundation announced today the selection of its 2024 class of Arnold O. Beckman Postdoctoral Fellows, individuals who underscore the Foundation's mission of supporting basic research in chemical sciences and chemical...

at 11:02
The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 ? 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP...

at 11:01
Somavedic, a trailblazer in sleep and digital pollution-neutralizing frequency therapy technology, in collaboration with researchers from the Eye Clinic of Jan Evangelista Purkyn? University and Masaryk Hospital in Ústí nad Labem in the Czech...

at 11:00
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen...



News published on and distributed by: